Is This Robotics Firm a Giant In The Making?
Inside operating rooms across the globe, a revolution has been underway, one led by Intuitive Surgical (NASDAQ: ISRG).
Over the past five years, the company has more than doubled its profits, yet many argue that it’s still in the early innings of growth.
Key Points
-
Intuitive Surgical has more than doubled profits in five years.
» Read more about: Is This Robotics Firm a Giant In The Making? »
Read More
This Move Might Reshape the Future of the Chip Industry
Lip-Bu Tan hasn’t been in the driver’s seat at Intel for long, but the new CEO is already making it clear that the era of open-ended spending is over. If Intel’s bleeding-edge chip manufacturing can’t justify its existence with real customer demand, it won’t get more money, period.
That kind of financial discipline might sound like corporate buzzkill,
» Read more about: This Move Might Reshape the Future of the Chip Industry »
Read More
Is Ambiq the Answer to AI’s Biggest Blind Spot?
AI might be the future, but that future has a power problem. For all the fanfare surrounding generative AI, one inconvenient truth continues to lurk in the background, which is it consumes an extraordinary amount of energy.
And unless someone cracks the code on power efficiency, scaling AI beyond the data center and into billions of edge devices will remain an expensive dream.
» Read more about: Is Ambiq the Answer to AI’s Biggest Blind Spot? »
Read More
Birkenstock Is Bouncing, Should Long-Term Investors Stay the Course?
Birkenstock sandals may be designed for comfort, but since going public, Birkenstock stock (NYSE: BIRK) has delivered more of a roller coaster than a relaxing stroll.
Over the past 12 months, shares have swung from gains in the mid-teens to losses twice that size, and as of today, they’re sitting roughly 8% in the red.
» Read more about: Birkenstock Is Bouncing, Should Long-Term Investors Stay the Course? »
Read More
Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read MoreThe Burst
Is Figma’s Stock a Falling Knife or a Hidden Bargain?
It didn’t take long for Figma to go from Wall Street’s darling to one of its biggest disappointments.
After a blockbuster debut this summer, the stock has been sliding steadily, leaving many early investors deep in the red. But is the sell-off a warning sign, or has the market simply overreacted?
Key Points
-
Figma grew revenue 41% year over year and turned a $178 million cash burn into $62.5 million in positive operating cash flow,
» Read more about: Is Figma’s Stock a Falling Knife or a Hidden Bargain? »
Read MoreThe Spotlight
Could Peloton Stock Deliver a 3-Bagger Comeback?
Remember when Peloton (NASDAQ: PTON) was the crown jewel of lockdown-era stocks? In early 2021, shares soared above $160, but today, it’s trading below $7.
The plunge may be the death knell for most stocks but here’s what might surprise most investors, beneath the wreckage, there are signs of a quiet but serious transformation.
» Read more about: Could Peloton Stock Deliver a 3-Bagger Comeback? »
Read MoreThe Daily
Social Security's Chief Says “Everything's Being Considered” to Combat Benefit Cuts — and While Unpopular, Raising the Full Retirement Age Should Be on the Table
Doing what’s popular isn’t always the best choice.
Since January 1940, Social Security has been providing a financial foundation for aging workers who could no longer do so for themselves. According to almost a quarter century of annual surveys from national pollster Gallup, between 80% and 90% of retirees rely on their monthly payout to cover at least some portion of their expenses.